These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25166007)

  • 1. The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry.
    Dandoit M; Mounier M; Guy J; Petrella T; Girard S; Casasnovas RO; Martin L; Bonnetain F; Maynadié M
    Leuk Lymphoma; 2015 Apr; 56(4):1050-7. PubMed ID: 25166007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer incidence in France over the 1980-2012 period: Hematological malignancies.
    Le Guyader-Peyrou S; Belot A; Maynadié M; Binder-Foucard F; Remontet L; Troussard X; Bossard N; Monnereau A;
    Rev Epidemiol Sante Publique; 2016 Apr; 64(2):103-12. PubMed ID: 26973179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia.
    Jayasekara H; Karahalios A; Juneja S; Thursfield V; Farrugia H; English DR; Giles GG
    Leuk Lymphoma; 2010 Mar; 51(3):456-68. PubMed ID: 20141433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.
    Marcos-Gragera R; Allemani C; Tereanu C; De Angelis R; Capocaccia R; Maynadie M; Luminari S; Ferretti S; Johannesen TB; Sankila R; Karjalainen-Lindsberg ML; Simonetti A; Martos MC; Raphaël M; Giraldo P; Sant M;
    Haematologica; 2011 May; 96(5):720-8. PubMed ID: 21330324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.
    Sant M; Allemani C; Tereanu C; De Angelis R; Capocaccia R; Visser O; Marcos-Gragera R; Maynadié M; Simonetti A; Lutz JM; Berrino F;
    Blood; 2010 Nov; 116(19):3724-34. PubMed ID: 20664057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006.
    Storm HH; Klint A; Tryggvadóttir L; Gislum M; Engholm G; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):694-712. PubMed ID: 20491526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).
    Li J; Smith A; Crouch S; Oliver S; Roman E
    Cancer Causes Control; 2016 Aug; 27(8):1019-26. PubMed ID: 27351920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of chronic myeloid leukemia and patient survival: results of five French population-based cancer registries 1980-2009.
    Penot A; Preux PM; Le Guyader S; Collignon A; Herry A; Dufour V; Monnereau A; Woronoff AS; Troussard X; Pons E; Bordessoule D; Maynadié M
    Leuk Lymphoma; 2015 Jun; 56(6):1771-7. PubMed ID: 25535815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
    van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM
    Int J Cancer; 2014 Nov; 135(9):2146-56. PubMed ID: 24639369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based incidence of childhood leukaemias and lymphomas in Spain (1993-2002).
    Marcos-Gragera R; Cervantes-Amat M; Vicente ML; de Sanjosé S; Guallar E; Godoy C; Calvo C; Giraldo P; Sant M; Peris-Bonet R; Carmen Martos M
    Eur J Cancer Prev; 2010 Jul; 19(4):247-55. PubMed ID: 20395866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult leukemia survival trends in the United States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995-2009.
    Bailey C; Richardson LC; Allemani C; Bonaventure A; Harewood R; Moore AR; Stewart SL; Weir HK; Coleman MP;
    Cancer; 2018 Oct; 124(19):3856-3867. PubMed ID: 30343495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood cancers in Chennai, India, 1990-2001: incidence and survival.
    Swaminathan R; Rama R; Shanta V
    Int J Cancer; 2008 Jun; 122(11):2607-11. PubMed ID: 18324630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France.
    Monnereau A; Troussard X; Belot A; Guizard AV; Woronoff AS; Bara S; Lapôtre-Ledoux B; Iwaz J; Tretarre B; Maynadié M;
    Int J Cancer; 2013 May; 132(10):2378-87. PubMed ID: 23034773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years.
    Linet MS; Brown LM; Mbulaiteye SM; Check D; Ostroumova E; Landgren A; Devesa SS
    Int J Cancer; 2016 Apr; 138(8):1862-74. PubMed ID: 26562742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R; Bazzeh F; Faqih N; Sultan I
    Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lorraine childhood cancer registry: incidence, survival 1983-1999].
    Lacour B; Desandes E; Mallol N; Sommelet D
    Arch Pediatr; 2005 Nov; 12(11):1577-86. PubMed ID: 16099145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.